CardioGenics Holdings Inc
CGNH
$0.0001
$0.000.00%
| 01/31/2016 | 10/31/2015 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -50.50% | 499.57% | |||
| Depreciation & Amortization | 5.88% | 21.43% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -35.48% | 212.01% | |||
| Operating Income | 35.48% | -212.01% | |||
| Income Before Tax | 65.87% | 39.97% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 65.87% | 39.97% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 65.87% | 39.97% | |||
| EBIT | 35.48% | -212.01% | |||
| EBITDA | 35.96% | -217.61% | |||
| EPS Basic | 64.52% | 50.00% | |||
| Normalized Basic EPS | 65.00% | 48.72% | |||
| EPS Diluted | 64.52% | 69.00% | |||
| Normalized Diluted EPS | 65.00% | 48.72% | |||
| Average Basic Shares Outstanding | -0.01% | 18.35% | |||
| Average Diluted Shares Outstanding | -0.01% | 18.35% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
